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Abstract
Background and objectives: The diagnosis of early oral potentially malignant disorders (OPMD) and oral squa-
mous cell carcinoma (OSCC) is of paramount clinical importance given the mortality rate of late stage disease. 
The aim of this study is to review the literature to assess the current situation and progress in this area. 
Material and Methods: A search in Cochrane and PubMed (January 2006 to December 2013) has been used with 
the key words “squamous cell carcinoma”, “early diagnosis” “oral cavity”, “Potentially Malignant Disorders” y 
“premalignant lesions”. The inclusion criteria were the use of techniques for early diagnosis of OSCC and OPMD, 
7 years aged articles and publications written in English, French or Spanish. The exclusion criteria were case re-
ports and studies in other languages. 
Results: Out of the 89 studies obtained initially from the search 60 articles were selected to be included in the sys-
tematic review: 1 metaanalysis, 17 systematic reviews, 35 prospective studies, 5 retrospective studies, 1 consensus 
and 1 semi-structured interviews. 
Conclusions: The best diagnostic technique is that which we have sufficient experience and training. Definitely 
tissue biopsy and histopathological examination should remain the gold standard for oral cancer diagnose. In this 
systematic review it has not been found sufficient scientific evidence on the majority of proposed techniques for 
early diagnosis of OSCC, therefore more extensive and exhaustive studies are needed.
Key words: Squamous cell carcinoma, early diagnosis, oral cavity, potentially malignant disorders, premalignant 
lesions.
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Introduction
Oral cavity cancer (OC) is a major health concern the 
world over (1), is defined as a malignant neoplasm on 
the lip or in the mouth (2) that ranks from the sixth to 
eight most common cancer around the world (3), with 
300.000 new cases reported every year (4-5). The 5-year 
survival rate has not improved for these patients remains 
at <50%, early  diagnosis and treatment of malignan-
cies usually optimizes long-term cure and survival (6). 
When the tumour disease is beyond and advanced stage 
(stage III-IV), the prognosis falls to 30-50%; whereas 
for diseases discovered early (stage I) the survival rate 
is 80% (5). Tissues that may be involved as the site of 
origin include the labial and buccal mucosa, the anterior 
two-thirds of the tongue, the retromolar pad, the floor 
of the mouth, the gingiva and the palate (7). The most 
common form of OC is Oral Squamous Cell Carcinoma 
(OSCC) (8), witch accounts for over 90% of malignant 
lesions in the mouth (3,9-12). The 5-years survival rate 
for OSCC has remained at approximately 50% over the 
past three decades (11,13-15).
The previous situations to the occurrence of a cancer 
are called premalignant lesions. Rethman et al. (7) de-
fines them like a morphologically altered tissue noted 
on clinical examination in which cancer is more likely 
to occur than in normal tissue; such lesions could be 
precancerous or premalignant and may exhibit epithe-
lial dysplasia (ED) on histopathologic examination. 
The World Health Organization (WHO) favors the term 
“Oral Potentially Malignant Disorders” (OPMD) for 
clinically recognized disease in which oral cancer may 
arise (9) as proposed Warnakurasuriya and cols. (16). 
This classification include: oral leukoplakia, oral eryth-
roplakia, oral lichen planus, nicotine stomatitis, tobacco 
pouch keratosis and oral submucous fibrosis (2). Leuko-
plakia is the most common OPMD (17-19) and its world-
wide prevalence is approximately 2,6% (20).
According to literature data, OPMD might turn into 
carcinoma in a percentage varying between 5-18% of 
cases (4,21). The presence of moderate or severe dyspla-
sia has been accepted to have the greatest likelihood for 
malignant transformation (14,19), ranging from 11-36% 
with a mean time of 33,6 months (14). As early cancer 
frequently been reported to be asymptomatic, the pres-
ence of symptoms that are not strongly indicative of car-
cinoma might induce general practitioners to interpret 
the symptoms incorrectly and consequently fail to refer 
the patients for investigation, resulting in diagnostic de-
lay (22).
The main risk factors, exogenous and endogenous, 
which are involved in the transformation of dysplastic 
oral epithelium are tobacco (1,7,15,23) which may play a 
synergistic role in oral tumorigenesis (23,24) and it’s as-
sociated with 75% of all cases of OC (12). Alcohol, has 
also been implicated in oral carcinogenesis not like a 
etiological specific factor but like adjuvant, acting both 
independently as well as synergically with smoking 
(7,23), being the risk of developing OC 30 times higher 
when associated of tobacco and alcohol (21). It has also 
been observed increased risk of OC people who have 
certain inherited diseases, such as Fanconi anemia (7) 
or leukoplakia patients (25). Human papilloma virus 
has more recently been identified as a leading etiologic 
risk factor in oropharyngeal SCC (15,24). Other viruses 
such as epstein barr virus or hepatitis C may also be 
related to the OC (12). 
The diagnosis of OPMD and OSCC is of paramount im-
portance given the mortality rate of late stage disease 
(26). Early recognition and diagnosis of OSCC might 
improve patient survival and reduce treatment-related 
morbidity (27). Therefore it is vital to know which meth-
ods are currently applied and his diagnostic accuracy.
In our experience based on the literature we have to em-
phasize the importance of methods toluidine blue stain-
ing and lugol staining for the screening of premalignant 
and malignant lesions of the oral cavity. The objective 
of this study is to review the literature to assess the 
current situation and progress in the early diagnosis of 
OSCC and OPMD.
Material and Methods
In this systematic review, a search in Cochrane and 
MEDLINE (PubMed) databases (January 2006 to De-
cember 2013) has been used with the key words “squa-
mous cell carcinoma”, “early diagnosis” “oral cavity”, 
“Potentially Malignant Disorders” y “premalignant le-
sions”.
The inclusion criteria were the use of techniques for ear-
ly diagnosis of OSCC or OPMD, 7 years aged articles 
and publications written in English, French or Spanish. 
The exclusion criteria were case reports and studies in 
other languages. The articles selection was agreed by 
consensus between the two authors; first by reading of 
titles and abstracts of the found bibliographic cites to 
identify the most relevant studies and then, by means 
of reading the full-text article. A summary that synthe-
sizes the techniques for early diagnosis of OSCC and 
TOPM that we have identified has been made (Table 1). 
Results
Out of the 89 studies obtained initially from the search 
(12 with Cochrane and 77 with Medline), 29 of these 89 
articles were excluded due to the lack of data and/or lack 
of direct relationship with the subject and finally, 60 ar-
ticles were selected to be included in the systematic re-
view: 1 metaanalysis, 17 systematic reviews, 35 prospec-
tive studies, 5 retrospective studies, 1 consensus and 1 
semi-structured interviews. The biography also cite some 
important articles referenced in the 60 selected articles.
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To establish a correct evaluation of any diagnostic test, 
several parameters must be considered: The sensitivity 
of a test, is the proportion of people who test positive for 
a specific disease among a group of people who have the 
disease. Specificity is the proportion of people who test 
negative for a specific disease among a group of people 
who do not have the disease. False positive is an errone-
ously positive test or screening result. False negative is 
an erroneously negative test or screening result. Positive 
predictive value (PPV) is the proportion of people in a 
specified population with positive test results who have 
the disease. Negative predictive value (NPV) is the pro-
portion of people in a specified population with negative 
test results who are disease-free.
The current protocol for detecting OPMD by conven-
tional oral examination (COE) involves visual inspec-
tion of the oral cavity and tactile examination of head 
and neck lymph nodes (11). The criteria for suspicion of 
an OPMD or OSCC include changes in surface texture, 
loss of surface integrity, color, size, contour deviation 
or mobility of intraoral or extraoral structures (28). A 
recent meta-analysis (29) reported 93% of sensitivity for 
the EOC, but specificity was only 31%. Therefore, EOC 
cannot reliably differentiate between benign and dys-
plastic lesions, and this is probably due to the fact that a 
number of benign conditions mimic oral malignancies.
The gold standard for COC or TOPM diagnosis re-
mains incisional biopsy (single or multiple) of the sus-
picious tissue and his histopathological examination 
(4,8,13,20,28,30). However, screening by taking random 
biopsies of both clinically normal and suspect oral tis-
sue is unpractical, since this causes serious discomfort 
to the patient and is not suitable for repeated sampling 
at multiple sites (30). As in other fields of medicine, di-
agnostic techniques of the oral cavity are going towards 
not painful, non-invasive, simple methods, inexpensive 
and accesive methods (31).
Discussion
In order to facilitate the understanding of this section, 
we have divided according to the most relevant tech-
niques or methods of early diagnosis of OSCC and 
OPMD that we have found in this systematic review.
1.-Vital Staining
Are techniques that use a range of pigments with a ten-
dency to focus on cells with high reproductive rate, as 
neoplastic cells, indicating the most suitable areas to 
practice biopsies and be controlled and examined. 
Bhalang et al. (10) conducted a study to assess the diag-
nostic accuracy of 5% acetic acid for COCE diagnosis. 
The sensitivity and specificity were 83,33% and 84,21% 
respectively. Sankaranarayanan et al. (32) who investi-
gated the detection of cervical cancer using 4% acetic 
acid reported a sensitivity and specificity of 88% and 
78% respectively. Although the use of this vital stain for 
the screening of CB appear to be interesting, are needed 
more studies to support its use (10).
Vital tissue staining with toluidine blue is the most used 
method for early detection of OPMD and OSCC. Is a 
cationic methachromatic dye that may selectively blind 
1. VITAL STAINING 
x 5% Acetic acid 
x Toluidine Blue 
x Methylene Blue 
x Lugol’s Iodine 
x Rose Bengal 
x Iodine staining 
x Tolonium chloride 
2. LIGHT-BASED
DETECTION
SYSTEMS 
x Tissue fluorescence imaging (Velscope, identafi 3000) 
x Chemiluminiscence (ViziLite plus, Microlux/DL) 
x Tissue fluorescence spectroscopy (NBI) 
3. HYSTOLOGICAL
TECHNIQUES
x Incisional biopsy 
x Excisional biopsy 
4. CYTOLOGICAL
TECHNIQUES
x Oral Brush biopsy (Oral CDX) 
x Liquid Based Cytology 
x Laser Microdisection (LCMd) 
5. MOLECULAR 
ANALYSES 
x Gene alterations 
x Epigenetic alterations, loss of Heterozygosity and Microsatellite instability 
x Viral genome studies 
x Proliferation index and AgNOR Analysis 
x Immunohistochemical identification of tumor markers. 
6. IMAGING 
TECHNIQUES
x FDG-PET 
x Optical Coherence Tomography (OCT) 
7. OTHER
TECHNIQUES x Onco-chips 
Table 1. Techniques that contribute to the diagnosis of oral cancer in addition to coe.
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to free anionic groups such as sulphate, phosphate and 
carboxylate radicals of large molecules. It can be useful 
due to the binding ability to the phosphate groups of the 
nucleic acids to be retained in the intercellular spaces 
of dysplastic epithelium (15). Epstein et al. (33), ex-
plain that toluidine blue sensitivity and specificity had 
a 92,5% and 63,2% respectively. One metaanalysis of 
Rosenberg et al. (34) previously published reported sen-
sitivity ranged from 93,5% to 97,8% and the specificity 
ranged from 73,3% to 92,9%. It’s practical, rapid, inex-
pensive, and effective adjunct diagnostic tool in mucosal 
disease. Its showed use in high-risk patients examined 
by experienced providers reduced the number of biop-
sies of benign lesions by approximately 50% and iden-
tified all severe dysplasia and OSCC lesions (15). The 
clinical application of toluidine blue has been shown to 
be selective staining of premalignant and malignant le-
sions (28), has a high sensitivity, but a low specificity 
due to the false positive that generates (29). So, is rec-
ommended as an adjunct to the clinical examination of 
oral mucosal lesions, specifically in high-risk patients 
by expert providers, but when stain is retained, all sus-
picious lesions should undergo biopsy (15). Moreover, 
that was shown to have toxicity to fibroblasts (13).
Another kind of dye material, methylene blue, dyes 
cells with acidophilic characteristic and may penetrate 
into cells with abnormal increase in nucleic acid, thus 
resulting in different uptake between normal and highly 
dysplastic/malignant cells. Chen et al. (13) investigated 
his diagnostic accuracy and results revealed sensitiv-
ity of 90%, specificity of 69%, PPV of 74% and NPV 
of 87%. The 90% sensitivity obtained was no less than 
the 72-100% sensitivities reported whit toluidine blue 
staining in other studies. The difference and also the 
most significant problem was the fact that there where 
three false negatives (10%). Authors conclude that con-
sidering its low toxicity and the fact that it is cheaper 
than toluidine blue it may be convenient to substitute 
toluidine blue in large-scale oral screening in high-risk 
patients. However, the histopathological report by inci-
sional biopsy must remain the gold standard. Remem-
bering that the histopathological study of the entire 
lesion with margins and depth control will give us the 
diagnosis of certainty.
Lugol’s Iodine staining having affinity for glycogen epi-
thelial cells, cells that contain more glycogen are going 
to retain more stain than those with lower content, such 
as carcinoma cells, in which the reaction with Lugol’s 
it’s not going to produce or very dim. In one study of 
Epstein et al. (33) Lugol’s iodine was proposed as CB 
screening technique and was described a sensitivity of 
87% and a specificity of 84%. Another study (35) ob-
served sensitivity, specificity, PPV and NPV for identi-
fying TOPM with Lugol’s iodine of 34,5%, 100%, 60,7% 
and 100% respectively. In some studies it is highlighted 
that the combined use of Lugol’s iodine and toluidine 
blue increases the specificity; Peng et al. (35) evaluated 
the results of double staining with Lugol’s Iodine and 
Methylene Blue values and they obtained 97,7%, 100%, 
97,8% and 100% respectively. In this study, this double 
staining significantly improves detection of OSCC and 
TOPM because combinations of both stains weakens 
the defects of each staining separately.
Du et al. (36) studied the efficacy of Rose Bengal stain-
ing. It was observed that the sensitivity for detect COCE 
and ED with the Rose Bengal stain was significantly 
higher that with visual examination (93,9% vs. 72,7%) 
while specificity was similar with both methods (73,7% 
vs. 76,8%). In this study there were false positive cases 
that were mostly caused by inflammation or trauma, 
fact that is observed in a similar way with the toluid-
ine blue stain, although it seems more promising in this 
study rose bengal staining to toluidine blue to detect 
the TOPM. They conclude that Rose Bengal staining 
is a valuable diagnostic test in detection of TOPM and 
OC. However further studies in larger samples sizes are 
needed. 
Watanabe et al. (37) verified the effectiveness of Iodine 
staining and obtained a sensitivity and specificity for 
detecting OSCC of 100% and 59,6%, respectively. The 
authors explain that iodine staining can be easily per-
formed and that helps in decision of surgical margin for 
locally resection. They conclude that the use of iodine 
staining as a part of clinical examination may be benefi-
cial for early detection of COCE in high-risk patients.
Finally, Patton et al. (38) in their study refer to the use of 
tolonium chloride that may bind preferentially to tissues 
undergoing rapid cell division. Rosenberg et al. (34) re-
ported an overall sensitivity of 93,5% and specificity of 
73,3%.
2.-Light-based detection systems 
They are devices featuring special light sources de-
signed according to principles of tissue reflectance and 
tissue autofluorescence to enhance the oral examina-
tion process (7), they function under the assumption 
that mucosal tissues undergoing abnormal metabolic 
or structural changes have different absorbance and 
reflectance profiles when exposed to various forms of 
light or energy (39). 
2.1.-Techniques of autofluorescence 
The technique involves illumination of suspicious lesions 
with monochromatic light and recording the fluorescence 
spectra emitted by endogenous tissue fluorophores (1). 
The presence of cellular alterations will change the con-
centrations of fluorophores, which will affect the scatter-
ing and absorption of light in the tissue, thus resulting in 
changes in color that can be observed visually (39). Ex-
posure to blue light spectra may maximize a differential 
profile in areas undergoing neoplastic change in which a 
loss of fluorescence visualization is reported (40).
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Jayanthi et al. (1) evaluates the potential of a multivari-
ate statistical algorithm to classify oral mucosa from 
autofluorescence spectral features recorded in vivo. 
They explore the potential of linear discriminant analy-
sis, to predict group membership of a sample with un-
known group. Marked differences were seen between 
autofluorescence spectra of healthy tissues (500nm) and 
malignant lesions (635-705nm). This method was able 
to differentiate pre-malignant ED from OSCC, benign 
hyperplasia from ED and hyperplasia from normal with 
overall sensitivities of 86%, 78% and 92%, and specifi-
cities of 90%, 100% and 100% respectively. The results 
obtained confirm the advantages of using multivariate 
statistical analysis on linear discriminant analysis spec-
tral data for non-invasive diagnosis of OPMD.
VELscope® is a device for direct visualization of 
changes in tissue fluorescence in the oral cavity that 
produce near ultraviolet/blue light between 400 and 
460 nm. Digital image processing images can be used 
to outline suspicious regions in real time. Rana et al. (4), 
in his study showed that using the VELscope® leads to 
higher sensitivity (100% vs. 17%), but to a lower spe-
cificity (74% vs. 97%) compared with COE. The major 
lack of the study was the large number of false-positive 
test results. In one other study of Koch et al. (40) show 
a high sensitivity (97%) and specificity (95,8%) to diag-
nose OSCC. The PPV was calculated at 41% and NPV 
at 75-80%. In another study of Moro et al. (21) they 
obtains a sensibility up to 100% and specificity up to 
93% to individualization of oral cancer in populations at 
risk. Finally Lane et al. (41) using histology at the gold 
standard, demonstrated a 98% sensitivity and a 100% 
specificity for discriminating ED and OC from normal 
oral mucosa.
VELscope® is a simple, noninvasive examination test 
of the oral mucosa with the ability to help locate malig-
nant oral lesions and find the right location for a biopsy 
(4), showing often limits of the lesion wider with the 
autofluorescence than those shown at clinical exami-
nation (21). The device could help to identify any type 
of pathological oral, but could not reliably distinguish 
benign oral lesions from dysplasia or OSCC (40), how-
ever it is very helpful in the diagnosis of OC (4,20). The 
results of the device should be interpreted with caution 
due to the issue of frequently occurring FP results and 
his low specificity (4), therefore, lesions showing a red 
autofluorescence signal should need further clarifica-
tion via histology (40). The device should not be used 
in the hands of unexperienced clinicians and cannot be 
a replacement for the gold standard of any histological 
evaluation (4,19).
McNamara et al. (42) concluded in his study that the 
results suggest that COE is more valid that autofluores-
cence examination (with VELscope®) in routine screen-
ing for OPMD. They do not support use of this device 
in routine screening assessment of asymptomatic den-
tal patients. And they believe that careful, systematic 
visual and tactile examination of the entire oral cavity 
on a regular basis remains the gold standard for early 
detection of OPMD. 
Another autofluorescence device is Identafi 3000® that 
combines anatomical imaging with fluorescence, fiber 
optics and confocal microscopy to map and delineate 
precisely the lesion in the area being screened. The ad-
vantage of this device over the VELscope® is its small 
size and easy accessibility to all tissues in the oral cav-
ity. One study of Schwarz et al. (43) demonstrated a 
sensitivity of 82% and a specificity of 87% in differ-
entiating between neoplastic and non-neoplastic oral 
conditions. Another study of McGee et al. (44) showed 
that healthy tissue could be discriminated from ED and 
OC with 100% sensitivity and 91,4% specificity. Finally 
Roblyer et al. (45) reported a capacity for discriminat-
ing between normal oral mucosa and ED or OSCC of 
96 to 100% sensitivity and 91 to 96 specificity. Further 
investigations of the device are needed to evaluate the 
clinical utility of this device (11).
2.2.-Autofluorescence techniques combined with endo-
scopic visualization methods
Narrow band imaging is an endoscopic visualization 
technology using the lighting created with optical in-
terference filters with different spectral ranges of low 
frequency. This technology utilize the concept that the 
wavelength of light determines the depth of penetration, 
therefore, the reflected photons constituting the images 
coming from different depths (surface and deeper lay-
ers) of the object that is explored. Bhatia et al. (11) did a 
literature research to evaluate the use of this technology 
in the oral cavity. He found only a few papers that have 
evaluated the use of narrow band imaging, and reported 
a Sensitivity, specificity, PPV, NPV for detecting OC 
ranged from 95 to 96%, 97 to 100%, 91 to 100% and 93 
to 99% respectively. In comparison the ranges for COE 
with white light were generally lower at 51 to 64%, 96 to 
100%, 82 to 100% and 87 to 90% respectively. Nguyen 
et al. (46) conducted a prospective study to evaluate 
combined autofluorescence and narrow band imaging 
for detection of OPMD and OC, they found a sensitivity 
for detecting moderate ED or worse at 96% with, which 
was better than white light which had only 38%.
2.3.-Chemiluminiscence 
Among the tissue-reflectance-based devices we found: 
The ViziLite Plus® that use a disposable chemilumines-
cent light packet. The Microlux/DL® and Orascoptic 
DK® that use a reusable, battery-powered light-emit-
ting diode (LED) light source that provides a similar 
blue-white (440 nm range) illumination. Under the blue-
white illumination, abnormal squamous epithelium is 
reported to be distinctly white (acetowhite). Vizilite 
Plus® also provides a toluidine blue solution which is 
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intended to mark an acetowhite lesion for subsequent 
biopsy (7,39).
It seems that the chemiluminescent exam using ViziLite 
Plus® helped to enhance the brightness, sharpness, tex-
ture and size of serious pathology lesions in comparison 
with COE under incandescent light (7,28,38,47). Some 
studies concluded that examination with the ViziLite 
did not change the diagnosis (4) and that they have not 
been shown to enhance the practitioner’s ability to iden-
tify OPMD not visible under normal operatory lighting 
(7). Different studies (7,35,39,47) show that ViziLite® 
device have high sensitivity (at 100%) but low specifi-
city (0 to 14%) and PPV (18 to 80%) when researchers 
confirmed its findings through histopathological exami-
nation. The sensitivity and specificity data for chemilu-
miniscent examination is not useful because only pa-
tients with visible lesions were included in the different 
studies, for the moment, the utility of enhanced visual 
findings in low-risk populations is not known.
That’s conclude Lingen et al. (39) the evidence that sup-
ports the use of reflective fluorescence systems to aid 
the detection of OPMD is currently quite sparse. Well-
controled clinical trials are needed that specifically in-
vestigate the ability of those devices to detect OPMD 
that are invisible by COE alone.
3.- Histological Techniques 
As already said, the best diagnostic method for OPMD 
or OSCC lesions is incisional (IB) or excisional biopsy 
(EB). One of the most useful prognostic indicators of 
malignancy is the severity of epithelial dysplasia; this 
is assessed with a biopsy, which allows histological 
examination and categorization according to features 
defined by the World Health Organization (WHO), clas-
sically into mild, moderate and severe. Histopathology 
also helps clinicians decide whether or not to make a 
split from the injuries, according to the perceived risk of 
malignant transformation. It also identifies the OSCC, 
even when lesions are not visible clinically. IB may not 
provide a representative sample of tissue from which 
the degree of dysplasia or presence of OSCC can be as-
sessed, so rates of malignant transformation might be 
more accurately measured from EB specimens. In this 
study we will focus on the new techniques of tissue pro-
curement, focusing on the laser.
Goodson et Thomson (48) assessed the correlation be-
tween diagnosis of dysplasia from IB and EB specimen. 
There was a significant correlation between the results 
of diagnostic incisional, and laser excision, biopsy spec-
imens, but 15 patients (9%), without high-risk features, 
had signs of occult invasive carcinoma in the excision 
specimens. Time interval between IB and laser excision 
in this study was 6 weeks, which suggest that focus of 
OSCC were present but missed at IB, presumably be-
cause of a sampling error. They explain that in 54% of 
cases histological examination of IB specimens was ac-
curate in predicting what they found on laser excision, 
however, in 28% of cases dysplasia was more severe in 
the laser excised specimen than in the IB specimen. In 
this study it’s not possible the presence of intraobserver 
variability by pathologists because the same team of 
specialist oral pathologists graded both incisional and 
excisional specimens, thus the differences reflect the 
inadequacy of incional biopsy specimens for the diag-
nosis of oral precancerous lesions. They conclude that 
complete excision of the lesion remains essential, not 
only to establish diagnosis but also to facilitate early 
efficacious treatment of both, dysplastic and early ne-
oplastic lesions, particularly at a stage when OSCC is 
clinically undetectable. 
It is important to remember that when making a BE 
must be verified that the margins and the depth of tis-
sue resected is disease-free, so if the BE is made with 
cold scalpel 1mm safety-margin should be respected, 
but if we made with CO2 laser, safety margins should 
be extended even to the 5mm to allow the pathologist be 
certain that excision was complete (49).
4.-Cytological Techniques
Cytopathology is the microscopic study of cell samples 
collected from mucosal surfaces (via smears, scrapings 
or lavage) or from internal sites via fine-needle aspira-
tion (39). The different articles reviewed, basically talks 
about two techniques, oral exfoliative cytology, which 
is the study of cells that flake off (naturally or artifi-
cially) from the oral mucosa, and liquid based cytology, 
where the sampling instrument is introduced into a liq-
uid medium immediately being fixed and avoiding sam-
ple degeneration over the air. 
The OralCDx® Brush Test system uses a specialized 
brush that collects transepithelial cellular samples com-
posed of free cells and clusters. These samples are fixed, 
stained and analyzed microscopically by a pathologist 
with a computer-based imaging system help (7,8,38), al-
lowing to evaluate lesions that do not immediately raise 
suspicion of OC (7). Rethman et al. (7), explains that 
Brush Test may help the practitioner identify the pres-
ence of atypical cells in seemingly innocuous mucosal 
lesions, but alerts of the high number of FP results, 
frequently obtained when this test is performed on in-
flammatory or reactive lesions. Fontes et al. (50) evalu-
ated the utility of oral cytopathology in the diagnosis 
of OSCC and earned a 83,1% of sensitivity, 100% of 
specificity, 100% of PPV and 49% of NPV. 
Kämmerer et al. (51) using Cytobrush®Plus GT ob-
tain a 55% of sensitivity and a specificity of 100% in 
comparison with histology. The PPV and NPV were 
100% and 80% respectively. Koch et al. (5) also using 
Cytobrush®Plus GT explain that depending of cyto-
logic criteria of malignancy used the diagnostic ac-
curacy varies. By defining all dysplastic or malignant 
cytopathologic findings as positive, the sensitivity was 
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increased to 95,2%, at the expense of the specificity, 
which was reduced from 94,9% to 82,3%. Separately 
analyzing OSCC of less than 20 mm, the sensitivity was 
reduced by 88,5% to 78%, and the specificity by 86,4% 
to 74,5%, as compared when all lesions of all tumor 
stages were considered.
The cytological study of oral cavity cells is simple and 
rapid, non-aggressive and relatively painless (52) that ap-
pears to be helpful in establishing a more definitive di-
agnosis in high-risk mucosal lesions (8,38,51). This test 
it seems of no value in detecting mucosal changes that 
are not readily visible to the naked eye (8). According to 
Patton et al. (38) data are insufficient to assess the Brush 
test’s utility in low-risk population or clinically innocu-
ous lesions. In contrast Kämmerer et al. (51) in their study 
were able to correctly classify all low-risk lesions. There 
is insufficient evidence to support a recommendation for 
or against the use of Oral brush test in seemingly innocu-
ous mucosal lesions, In the case of “atypical” result or 
positive result (ED or OSCC) it should be biopsied im-
mediately for a better diagnosis (7).
Delavarian et al. (31) studied the diagnostic accuracy 
of liquid based citology technique in detection of ED/
OSCC using a specialized oral brush (OralCDx® 
Brush). This technique suggests a higher sensitivity 
and specificity compared with COE, with witch was in 
agreement in 88,4% of cases. Brush diagnosis it was in 
92,3% with histopathological findings. The results ob-
tained (sensitivity 88,8%, specificity 100%, PPV 100% 
and NPV 80%) suggest that this technique is a suitable 
test for clinical use, and that permits eliminate some of 
disadvantages of the conventional brush. It is vital to 
understand that cytology has a low NPV, a negative re-
sult does not exclude ED or OSCC, repeated biopsy is 
required if the first biopsy proves negative (9).
5.-Molecular Analyses
Grading of OPMD by molecular methods seems more 
promising because reduce the inter- and intraobserver 
variability of histology (30). OC arise as a result of the ac-
cumulation of genetic alterations in proto-oncogenes and 
tumor suppressor genes (24,30). These genetic changes 
are of value to predict the risk for malignant progression. 
On the other hand, numerous chromosomal regions have 
been associated with early OSCC carcinogenesis and 
should therefore be analyzed in parallel (30). Lingen et al. 
(24) highlight that development of molecularly based ap-
proaches to identify predictive biomarkers could be used 
to improve the potential for early detection, prognostica-
tion and intervention of OC. 
5.1.-Gene alterations 
Most of the oral cavity carcinogens are mutagenic agents 
that may cause changes in gene and chromosome struc-
ture by point mutations, deletions, insertions and rear-
rangements. These genetic alterations can be used as tar-
gets for detecting tumour cells in clinical samples (52). 
Mutations in the tumour suppressor gene p53 are the 
most frequent genetic alterations in OSCC (10,52,53) 
with published figures ranging from 35% to 94% (10,53). 
His function is to regulate a cell cycle checkpoint and 
the induction of apoptosis in response to DNA dam-
age (10). However, other authors consider that the high 
number of point mutations, which can be found in p53, 
limit its potential clinical application (52). Even if its 
predictive value has been controversial, p53 mutations 
may be an important event, early or late in the progres-
sion of OPMD (53). It has been demonstrated the poten-
tial clinical application of oral cytology to detects them 
(52), cause elevated transcription of the mutant p53 gene 
contributes to the overall high levels of the mutant pro-
tein in tumor cells and results in the accumulation of 
this protein in the nucleus that can be detected immuno-
histochemically (20).
Aneuploidy is another genetic alteration that refers to 
the change in chromosomal number (result from gene 
dose imbalance, loss of TSG, gain of tumor promoting 
genes or oncogenes, or formation of fusion genes) (24). 
Aneuploidy is observed in 20-92% of oral dysplasia 
(24,54). Donadini et al. (54) demonstrated that OPMD 
that could be clinically classified without ED at histol-
ogy, contained alredy DNA aneuploidy sublines in 23% 
of the cases. In the study of Kämmere et al. (51) the de-
tection of aneuploidy, which is the basis of DNA-Image 
cytometry (DNA-ICM), reported 70% sensitivity, 100% 
specificity, 100% PPV and 86% NPV. The combination 
of DNA-ICM with Brush Biopsy showed a sensitivity 
of 76% and a specificity of 100%. The predominant 
reason for FP results in this study was sampling errors 
with insufficient cells. In other study (6) the sensitivity 
of DNA-aneuploidy on oral smears for the detection of 
cancer cells was 90%, the specificity 100%, PPV 100% 
and NPV 93% (6). It seems that DNA-ICM has the po-
tential to substantially improve sensitivity, therefore 
should not be used to rule out malignancy, when lesions 
are already clinically suspicious for OC but rather as 
an adjunct to improve the quality of brush biopsy as a 
screening instrument (51). 
Finally, another gene alteration that is related to OC is 
miRNA. Lingen et al. (24) conclude that for the moment 
there are insufficient evidence available to delinate rec-
ommendations regarding the clinical utility of miRNA 
expression and the prediction of whether a OPMD will 
progress to OSCC (24).
5.2.-Epigenetic alterations, loss of heterozygosity and 
microsatellite instability
The applicability of other molecular markers such as 
epigenetic alterations (hypermethylation of promoter 
regions) and genomic instability such as loss of hetro-
zygosity (LOH) and microsatellite instability (MSI) has 
also been studied.
The main epigenetic modification in tumours is methyl-
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ation. Rosas et al. (55) studied the methylation patterns 
of p16, MGMT and DAP-K genes in smears of patients 
suffering from head and neck cancer, using a methyla-
tion specific Polymerase Chain Reaction (PCR). They 
explains that this technique allows sensitive and effi-
cient detection of tumoral DNA. Huang et al. (56) that 
use PCR techniques to amplify DNA from exfoliated 
cytology samples from oral carcinomas, for analysis of 
restriction-fragment length polymorphisms. They found 
that 66% of the tumors studied showed LOH at one po-
sition in the p53 sequence. Nunes et al. (57) find LOH in 
84% of the samples, though with differences depending 
on tumour stage. Other studies have been used PCR and 
RFLPs to detect microsatellite markers, i.e. short repeti-
tive DNA sequences, these demonstrated that alterations 
in certain regions of chromosomes 3p, 9p, 11q, 17p are 
associated with development of OSCC (52). Bremmer et 
al. (25) in his study detected allelic inestability at these 
regions using microsatellite markers in exfoliated cell 
samples of 40% with a 78% of sensitivity and a PPV of 
100% (24). Partridge et al. (58) observed that LOH at 3p 
and 9p in 90% of cases progress to cancer.
Bremmer et al. (30) applied a novel genetic assay, “the 
multiplex ligation-dependent probe amplification”, that 
enables the measurement of gains and losses at 40 dif-
ferent chromosomal location in one PCR reaction using 
150 ng DNA. The assay was correlated to loss of het-
erozigosity analysis using microsatellite markers. They 
conclude that this technique is a sensitive, reliable, high-
throughput and easy-to-perform, enabling the detection 
of genetic alteration on small noninvasive samples and 
can be considered a promising method for population-
based screening of OPMD in the oral cavity. Lingen et 
al. (24), says that comparison among existent studies is 
challenged by methodologic differences, adjustment for 
confounders, and controls, thus, the clinical utility of 
LOH in 3p and 9p as an effective screen for progression 
of OPMD to OSCC requires prospective validation.
5.3.-Viral genome studies
A significant proportion of oropharyngeal cancers (40-
60%) have human papilloma virus DNA integrated 
within their genomic DNA. Archival cytology slides 
can also be used for this DNA detection with “in situ” 
hybridation. The diagnostic of metastatic lesions usu-
ally is determined by fine-needle aspiration. With this 
technique is used alcohol-fixed, archival, cytopatho-
logical material to study the presence of HPV-DNA. It 
presence was correlated with the origin of metastatic 
lesions (52).
5.4.-Proliferation index and AgNOR Analysis 
Remmerbach et al. (59) demonstrated the validity of 
oral cytology for analyzing the number of keratinized 
cells and the nucleolar activity (AgNORs), the authors 
concluded in this study that AgNOR analysis may be 
used as a routine method for diagnosing oral cancer. 
Another study. (6) apply for the first time a multimodal 
cell analysis, that was based on the sequential applica-
tion of multiple staining of identical, slide-based cells 
and repeated relocalization and measurements of their 
diagnostic features, resulting in multiparametric fea-
tures of individuals cells. The stepwise application of 
the two additional approaches (morphology, DNA con-
tent, AgNOR) increased the specificity of conventional 
cytologic diagnosis from 92,6% to 100%. The study 
demonstrated that this methode may become a sensi-
tive and highly specific, objective, and reproducible ad-
juvant diagnostic tool for the identification of neoplastic 
changes in oral smears that contain only a few abnormal 
cells.
5.5.-Immunohistochemical identification of tumor 
markers
The identification of tumoral markers, notably cytok-
eratins in smears from the oral cavity provides useful 
information on cell differentiation status, but its poten-
tial for early diagnosis of oral cancer is limited. Howev-
er, certain cytokeratins, such as K8 and K19 are useful 
if not definitive indicators of malignancy, particularly if 
their presence is interpreted in conjunction with other 
information, such as DNA profile (52). 
For the other hand, Vascular endothelial growth factor 
(VEGF) plays a central role in regulating angiogenesis 
in solid tumors and is tightly associated with the ang-
iogenic switch being crucial in the progression of the 
ED to invasive OSCC. Serum VEGF-A levels have been 
reported to be elevated in OSCC and have also been cor-
related with lymph node metastasis and clinical staging. 
Nayak et al. (60) make a inmunohistochimical study 
to evaluate the expression of circulating VEGF-A (by 
ELISA assay) and in tissues (using antibodies against 
VEGF-A and CD-34). Serum VEGF-A levels and im-
munohistochemical VEGF-A expression showed more 
than 50-fold increase in OMPD and OSCC in compari-
son with controls. VEGF-A levels in serum correlated 
in a linear fashion with the tissue expression in oral pre-
malignant and malignant lesions. This seems to be an 
important finding for predicting progression of OMPD 
to OSCC. However this would require a well-controlled 
large scale, multicentric study in different geographical 
locations along with clinic-epidemiological, etiological 
factors and follow up studies for serum VEGF expres-
sion in post treatment cases.
Finally, also may be important the immunocytochemi-
cal of the minichromosome maintenance (MCM) pro-
teins. They seem to be sensitive and specific biomarkers 
of cell cycle entry that are essential for eukaryotic DNA 
replication. Scott et al. (61) conducted a study in which 
they observed striking differences in expression of this 
proteins in the surface layers of epithelium showing 
severe/moderate ED or OSCC, compared to mildly ED 
or benign lesions. They undertook MCM immunocyto-
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chemistry of oral smears and they cytological data were 
fully consistent with the histopathological observations 
and indicate that MCM-positive epithelial cells are like-
ly to be present in smears from OSCC but not in scrapes 
of mild ED and benign keratosis. They conclude that the 
strong clinical performance and ready interpretation of 
stained liquid based citology samples make MCMs par-
ticularly strong markers for high-throughput screening 
of high-risk patients. 
6.-Imaging diagnostic techniques
The imaging diagnostic techniques are divided into 
radiographic techniques, nuclear medicine, magnetic 
resonance and ultrasonography. In this work we review 
some of nuclear medicine techniques, focusing on: posi-
tron emission tomography (PET) that it’s a functional 
imaging technique that provides information about 
tissue metabolism and optical coherence tomography 
(OCT) that is a noninvasive high-resolution imaging 
modality capable of cross-sectional imaging of biologi-
cal tissue using back-scattered signals reflected from 
different layers within the tissue to reconstruct struc-
tural images.
Finally we will comment polarimetry a technique that 
measured the polarization effects of the scattered light 
from bacterial suspensions to yield useful information 
to characterize the sample. This technique allows to 
visualize different useful factors for differentiating be-
tween cancerous tissues and his homologous benign.
Liao et al. (62) prospectively examined the value of pos-
itron emission tomography using the fludeoxyglucose 
(FDG) molecule immediately before postoperative radi-
otherapy/concurrent chemo radiotherapy to detect resid-
ual/relapsing disease in the early postsurgical follow-up 
period in high-risk OSCC patients. Of the patients who 
underwent the second scan 24% had unexpected, newly 
discovered lesions. At two months rates of neck control, 
distant metastases, and disease free survival were sig-
nificantly higher in patients who received a second PET 
scan than in those who did not. The authors conclude 
that the findings support the clinical value of FDG-PET 
for defending treatment strategy in OSCC patients with 
both extra capsular spread and nodal standardized up-
take value. 
Hamdoon et al. (63) in his study conclude that OCT 
achieve a sensitivity, a specificity, PPV and NPV for de-
tecting OPMD and OC of 85%, 78%, 86,5% and 77,5% 
respectively. In contrast, Jerjes et al. (64) confirms the 
feasibility of using OCT to identify architectural chang-
es in malignant tissues but reported that its ability to 
differentiate between different oral mucosal abnormali-
ties was poor. Further research is required on the poten-
tial application of OCT to improve and define excisional 
margins during surgical management of OPMDs and 
OSCCs (11). 
Ahn et al. (65), determine a multimodality approach 
to noninvasive diagnosis of OPMDs and OSCCs in 
hamsters, “in vivo” polarimetry of the oral mucosa 
was used to acquire mueller matrix images providing 
quantitative information on epithelial tissues and OCT 
was used to map epithelial and subepithelial changes 
throughout carcinogenesis demonstrating the feasibil-
ity of diagnostic imaging within the oral cavity using 
these modalities. From OCT images, surface and sub-
surface structure including blood vessels were clearly 
visible with epithelial and subepithelial changes evident 
in the OCT images paralleling histopathological status. 
Polarimetry techniques identified a four to five times 
increased retardance in sites with SCC and two to three 
times greater retardance in dysplastic sites than in the 
normal tissues. Taken together, these two techniques 
could provide useful information for screening patients 
for oral cancer, and it’s particularly useful for mapping 
areas of field cancerization with multiple lesions, as 
well as lesion margins.
7.-Other new Approaches
Finally found one article of Mehrotra et Yadav (23) 
who talk about the “Onco-chips”, which consist of a 
full array of small cells in which genes suspected to be 
associated with cancer are introduced. Onco-chips are 
the new concept consisting of several reliable diagnos-
tic head and neck cancer markers, wich may be used to 
diagnose cancer. The treatment of cells with therapeutic 
chemicals, has been shown to produce specific changes 
in gene expression. It is a technique that is in develop-
ment at the moment but that is potentially interesting.
Conclusion
The best diagnostic technique is that which we have 
sufficient experience and training. Definitely tissue bi-
opsy and histopathological examination should remain 
the gold standard for oral cancer diagnose. 
With oral cytology we can obtain single cells that can 
be analyzed using sophisticated techniques such as cy-
tomorphometry and molecular analysis or using more 
simple techniques such as toluidine blue (dye most used) 
or rose bengal (which has proved more promising), with 
all these techniques have been achieved very interest-
ing results. On the other hand, optical techniques and 
diagnostic techniques for imaging have also proved par-
ticularly useful, but their results are not yet clinically 
relevant.
In this systematic review it has not been found sufficient 
scientific evidence on the majority of proposed tech-
niques for early diagnosis of OPMD and OSCC, there-
fore more extensive and exhaustive studies are needed.
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